Pharmaceutical composition for keratosis and use thereof

JPWO2026004998A5Active Publication Date: 2026-06-09TANABE PHARMA CORP
View PDF 0 Cites 0 Cited by

Patent Information

Authority / Receiving Office
JP · JP
Patent Type
Patents
Current Assignee / Owner
TANABE PHARMA CORP
Filing Date
2025-06-27
Publication Date
2026-06-09

Smart Images

  • Figure 00000027_0000
    Figure 00000027_0000
  • Figure 00000027_0001
    Figure 00000027_0001
  • Figure 00000027_0002
    Figure 00000027_0002
Patent Text Reader

Abstract

A new pharmaceutical composition for treating keratosis including Darier's disease and psoriasis is provided. The pharmaceutical composition for treating keratosis of the present invention contains 5-methyl-2-(1-piperazinyl)benzenesulfonic acid. The compound is an anhydride, a salt, a hydrate, or a solvate thereof, or a hydrate or solvate of a salt thereof, and the hydrate is, for example, 5-methyl-2-(1-piperazinyl)benzenesulfonic acid monohydrate. The keratosis is, for example, Darier's disease or psoriasis.
Need to check novelty before this filing date? Find Prior Art